Key Rapid Influenza Diagnostics Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Quidel Corporation
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company (BD)
- Meridian Bioscience Inc.
- DiaSorin S.p.A.
- Sekisui Diagnostics LLC
- Siemens Healthineers AG
- Danaher Corporation
- Luminex Corporation
- bioMérieux SA
- Hologic Inc.
- Abbott Laboratories
- Seegene Inc.
As the rapid influenza diagnostics market is growing steadily, the main competitors, such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Quidel Corporation, are focusing on innovation and product development. Besides, Abbott’s ID NOW Influenza A & B 2 test provides quick results at the point of care to meet the demand for rapid diagnosis, which is positively impacting the overall market globally. Moreover, as companies compete to improve accuracy, speed, and accessibility, they are adjusting to the growing global demand, which further denotes a huge growth opportunity for the market across different nations.
Here is a list of key players operating in the global market: